Each one in plain English, with the numbers worked through for a shareholder.
16 Oct 2020capital raising announcement▲ Good
3,876,843 listed options were exercised at 6.79c, raising $263,238. Shares on issue rise to about 703.1m, with about 107.3m listed options remaining until expiry on 31 December 2020. Small but growing cash inflow.
264,000 listed options were exercised at 6.79c, raising $17,626. Shares on issue rise to about 699.2m, with about 111.2m listed options remaining before they expire on 31 December 2020. Very small sum.
704,539 listed options exercised at 6.79c raised $47,838. Also 2.5m shares issued to directors at 2c from the May placement after AGM approval. Shares on issue rise to about 699.0m; about 111.4m listed options remain.
Another 2,528,407 listed options at 6.79c were exercised, raising $171,679 and lifting shares on issue to 695.8m. Listed options remaining fall to about 112.1m. A small ongoing source of cash before the options expire on 31 December 2020.
Holders applied to exercise 2,266,919 listed options at 6.79c, paying $153,924. The managing director linked this to the recent strong share price. The company had 118.6m listed options before the exercise, and they expire on 31 December 2020.
26 May 2020capital raising announcement▲ GoodMajor
The Share Purchase Plan drew over $2.9m of applications against a $0.25m target, and was capped at about $1.65m. With the placement, total raised rises to $3.35m, assuming director participation is approved, funding more seismic and strat-holes.
Offer booklet for the Share Purchase Plan: eligible holders can apply for up to $30,000 of shares at 2c, the same price as the placement, targeting $0.25m. Applications close 22 May. Terms follow the 6 May announcement; no new information.
6 May 2020capital raising announcement● NeutralMajor
Elixir raised $1.75m through a placement of 87.5m shares at 2c, a 20% discount to the 5-day VWAP, with a further $0.25m targeted via a Share Purchase Plan. Funds pay for delineation and exploration drilling from early July, feeding a maiden contingent resource report later in the year.
What it means for a shareholder
87.5m new shares at A$0.020 to raise about A$1.8m. That's 15% dilution: every existing holder's slice gets 15% smaller. If you held A$1,000 of shares (50,000 at the issue price), your slice goes from 0.00998% to 0.0085% of the company. To keep it you'd need 8,735 more shares - about A$175 at the issue price.
Cleansing prospectus (offer of 1,000 shares at 6c) to allow free resale of shares from option exercise. Raises no meaningful money itself. Records 93.46m listed options at 6.79c and 8m unlisted at 3.29c.
What it means for a shareholder
1,000 new shares at A$0.060 to raise about A$60. That's 0.000205% dilution: every existing holder's slice gets 0.000205% smaller. If you held A$1,000 of shares (16,667 at the issue price), your slice goes from 0.00342% to 0.00342% of the company. To keep it you'd need 0 more shares - about A$0 at the issue price.
Placement completed: 97,440,807 shares issued on 24 May at 3.6c, about 25% dilution. Joint lead managers get a 6% fee plus 9.74m EXROA options, subject to shareholder approval. Funds go to the Mongolian exploration program and working capital.
What it means for a shareholder
97.4m new shares at A$0.036 to raise about A$3.5m. That's 17% dilution: every existing holder's slice gets 17% smaller. If you held A$1,000 of shares (27,778 at the issue price), your slice goes from 0.0057% to 0.00475% of the company. To keep it you'd need 5,556 more shares - about A$200 at the issue price.
Cleansing prospectus (offer of 1,000 shares at 3.6c) lodged to allow free resale of the May placement shares. It raises no new money of its own, and the text shows the placement as 97,440,807 shares for about $3.5m.
What it means for a shareholder
1,000 new shares at A$0.036 to raise about A$36. That's 0.000257% dilution: every existing holder's slice gets 0.000257% smaller. If you held A$1,000 of shares (27,778 at the issue price), your slice goes from 0.00713% to 0.00713% of the company. To keep it you'd need 0 more shares - about A$0 at the issue price.
15 May 2019capital raising announcement▲ GoodMajor
Placement of 99.4m shares at 3.6c raises about $3.6m, leaving about $4.8m cash and 487m shares. Also: Mongolian exploration licence issued (10-year term), company renamed Elixir Energy, Neil Young made Managing Director. Detailed EIA still outstanding.
What it means for a shareholder
99.4m new shares at A$0.036 to raise about A$3.6m. That's 20% dilution: every existing holder's slice gets 20% smaller. If you held A$1,000 of shares (27,778 at the issue price), your slice goes from 0.00713% to 0.00568% of the company. To keep it you'd need 7,084 more shares - about A$255 at the issue price.
The full 76.3m-option shortfall was placed, raising $762,525 and taking the option offer total to $934,625 before costs. Entek deal now expected to complete about 10 April 2019, returning about US$1.34m, or about US$840,000 net of the loan, for Mongolia.
Lists the top 20 holders of the new options issued on 29 January 2019 (EXROA); they hold 10.44m, or 60.67%, across 130 holders. Compliance disclosure only, to be updated if shortfall is placed.
The option offer drew applications for only 17.2m of the up to 96.2m options, raising $171,975. The 76.3m shortfall options (up to $762,524) go to Directors to place with investors via lead managers Xcel Capital and Originate Capital.
Reminder that the option offer closes 21 January 2019 and will not be extended. Says proceeds support the Mongolian 2D seismic survey (Q2 2019) and a minimum two-well coal seam gas drilling program from Q3 2019, with pilot testing in 2020.
Elixir posted the prospectus and application forms for the 1-for-4 option offer (1 cent, 7.5 cent exercise, to 31 December 2020). It closes 21 January 2019, with any shortfall expected to be placed by 29 January. Administrative; no new terms.
Administrative notice to shareholders on the option offer: 1 option per 4 shares at 1 cent, exercisable at 7.5 cents to 31 December 2020, record date 21 December 2018, closing 21 January 2019. Up to $961,908 could be raised. Repeats the 14 December terms.
14 Dec 2018capital raising announcement● NeutralMajor
Elixir launched a non-renounceable offer of up to 96.2m options, one for every four shares, at 1 cent each, exercisable at 7.5 cents by 31 December 2020. It would raise up to about $961,908, not underwritten, for exploration and Mongolian work.
The prospectus for the option offer: up to 96.19m options at 1 cent, exercisable at 7.5 cents to 31 December 2020, closing 21 January 2019. It also covers a 1,000-share offer at $0.05 to allow secondary trading of the GOH consideration shares. No new detail beyond the 14 December announcement.
Prospectus for 1,000 shares at $0.05, issued only to facilitate secondary trading of the bonus issue shares announced 1 November. No new funds of substance are raised.
Prospectus for 1,000 shares at $0.05, issued only to allow secondary trading of the 33m placement shares (about $1.65m) announced 12 September. No new money of substance is raised.
What it means for a shareholder
1,000 new shares at A$0.050 to raise about A$50. That's 0.000452% dilution: every existing holder's slice gets 0.000452% smaller. If you held A$1,000 of shares (20,000 at the issue price), your slice goes from 0.00903% to 0.00903% of the company. To keep it you'd need 0 more shares - about A$0 at the issue price.
Compliance notice for the issue of 42,500,000 placement shares, diluting existing holders by 23.8%. The placement funds the Golden Horde condition, at a 2.5% discount to the 15-day average price, with a 6% broker fee plus 2,500,000 shares to helpers. Also discloses a pending New Zealand block application.
The whole rights issue shortfall was placed with professional investors, raising a further $1,205,218. Total raised since 30 June 2016 is about $2.23m before costs, and shares on issue are 178,946,872. This completes the recapitalisation.
Rights issue closed with only $584,250 of the up to $1,789,468 taken up by shareholders. The remaining 60,260,891 shares ($1,205,218) go to directors to place with professional investors. Shareholder demand covered about a third of the offer.
Rights issue offer documents were posted to eligible shareholders on 7 September. The offer is expected to close on 20 September. Timetable only, no new terms.
Letter to shareholders announcing the 1:1 non-renounceable rights issue at $0.02, raising up to about $1.79m. Offer documents go out 7 September and the offer closes 20 September. It repeats terms already announced.
Letter telling shareholders with addresses outside Australia and New Zealand that they cannot take part in the $0.02, 1:1 rights issue. The company judged extending it to them unreasonable on cost and holder numbers. No action is needed.
Letter to option holders on the 1:1 rights issue at $0.02 per share, raising up to about $1.79m from 89.5m shares. Option holders can take part only by exercising before the 6 September record date. Offer closes 20 September.
What it means for a shareholder
89.5m new shares at about A$0.020 to raise about A$1.8m. That's 33% dilution: every existing holder's slice gets 33% smaller. If you held A$1,000 of shares (50,000 at the issue price), your slice goes from 0.0279% to 0.0186% of the company. To keep it you'd need 25,007 more shares - about A$500 at the issue price.
17 Aug 2016capital raising announcement● NeutralMajor
After shareholder approval on 16 August, Tranche 2 of the placement completed, raising $205,962 through 257,451,932 pre-consolidation shares. The 25-to-1 consolidation follows, then a 1:1 rights issue of about $1.8m, leaving about 179 million shares. This resolves the pending approval.